Seeking Alpha

Salix Pharmaceuticals (SLXP): Q4 EPS of $0.81 beats by $0.03. Revenue of $198.1M misses by...

Salix Pharmaceuticals (SLXP): Q4 EPS of $0.81 beats by $0.03. Revenue of $198.1M misses by $1.31M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)